Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Access to Health Services

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Also In Global Health News: Asia’s ‘Double Burden'; Guinea Worm Eradication; ARV, Antibiotic Treatment; Sierra Leone’s Medical Workers; Melinda Gates In India

Asians Facing ‘Double Burden’ Of Disease, Health Experts Warn During a two-day healthcare conference in Asia, health experts on Monday encouraged the governments of Asian countries to draft plans to tackle the long-term costs associated with chronic illnesses, Reuters reports. “Asia is facing a double burden,” of disease, said Bruce…

British Government, HIV/AIDS Advocates Warn Decreased Aid Budgets Could Lead To Reversals In HIV/AIDS Treatment Progress

Recent gains in the global fight against HIV/AIDS could be reversed as the “global economic downturn pinches poor countries’ budgets and donors show signs of backing away from their promise to provide universal access to AIDS treatment,” the British government together with Medecins Sans Frontieres (MSF) warned Tuesday, Reuters AlertNet reports.

Also In Global Health News: Child, Maternal Mortality; AIDS 2010; Food Aid To N. Korea; Millennium Challenge Corporation; Family Planning Conference; Parasitic Disease Test

AU Summit To Examine Progress Toward Child, Maternal Mortality MDGs When leaders of African states gather for the African Union summit in Kampala, Uganda, in July, they will assess the continent’s progress towards achieving the Millennium Development Goals relating to child and maternal mortality, Isaac Musumba, Uganda’s state minister for…

GlaxoSmithKline, Pfizer Will Supply 600M Doses Of Reduced-Price Pneumococcal Vaccines To Developing Countries Over 10 Years, GAVI Says

The GAVI Alliance on Tuesday formally announced that drugmakers GlaxoSmithKline and Pfizer had signed off on a “10-year deal … to supply 60 million doses a year of cut-price pneumococcal vaccines to developing nations,” Reuters reports. The agreement is under what’s “called an Advance Market Commitment (AMC) which guarantees a market for vaccines supplied to poor nations but sets a maximum price drugmakers can expect to receive,” the news service writes (Kelland, 3/23).

Goosby, Emanuel Address Progress, Potential Roadblocks Ahead For Introduction Of Microbicides In Developing Countries

The growing evidence supporting the promise of new HIV prevention products, like microbicides, requires that groups start planning now for how best to roll-out prevention interventions in the future, U.S. Global AIDS Coordinator Eric Goosby and Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said Monday during a USAID Microbicide Stakeholders Meeting in Washington.

WHO Report Calls For Countries To Improve Access To Health Services

“Tens of millions of people are pushed into poverty each year as a result of rising costs for health care, the World Health Organization said Monday” as the agency released a report on financing health systems and universal coverage, Deutsche Presse-Agentur/M&C reports. It also highlights the vulnerability of populations without access to health care services and outlines the steps countries can take to move toward universal health care, according to the article (11/22).

Report Documents Increase In R&D Projects On Developing World Diseases

“Drugmakers are now working on over 100 R&D projects designed to tackle diseases of the developing world and almost 80% of them are being carried out with non-industry partners,” according to a report (.pdf) released on Wednesday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Pharma Times reports.

Recent Releases In Global Health

Developing World Access To Medication: “Access to life-saving, essential medicines must be improved,” Josh Ruxin, founder and director of the Access Project and director of Rwanda Works, writes in a Forbes’ “Science Business” blog. After looking at the debate over whether the free market can help improve access and examining programs,…